Clinical adverse effects of natalizumab
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000011507
Abstract: Background: Natalizumab (NAT), a humanized monoclonal antibody, which binds in both &agr;4&bgr;1 integrins and &agr;4&bgr;7 integrins, is approved for the treatment of multiple sclerosis (MS) and Crohn's disease (CD). An uncommon but serious adverse event… read more here.
Keywords: aes; medicine; effects natalizumab; clinical adverse ... See more keywords